Director, Scientific Business Development

Description Insightec is a growing medical technology company transforming patient lives through innovative incisionless surgery. Our culture is as unique as our people, a diverse global team, with different ideas, skills, interests, and cultural backgrounds driven by our core values – Our Patients, Integrity, Team, Quality and Innovation. Our dedication to making a real impact on the lives of millions of people and paving the path to a bright future for healthcare, is what bonds us as a Team. We work together in a dynamic collaborative environment to deliver successfully while believing and driving a life-work balance philosophy that encourages our employees to do things that are meaningful outside of work. Every role is significant, your voice is heard, and your ideas are encouraged. We challenge and empower our people to be great at what they do while providing a flexible work environment. Walking through our corridors, you will be inspired by stories of career journeys at Insightec. We take pride in growing internal talent and encourage our employees to achieve their professional ambitions. With employees in Israel - Haifa and K. Ono, Miami and Dallas, Shanghai, Tokyo and Europe, we offer in each region competitive perks and benefits. Do the most meaningful work of your career by joining us on our mission to transform tomorrows, today. Role Purpose Lead the scientific and business development strategy connecting our BBBo-FUS platform with the neuro-biotech ecosystem. The role integrates scientific evaluation, partnership development, and strategic deal execution to accelerate pre-clinical and translational to early clinical programs. Role will focus on our core strategic alliance portfolio (i.e., LOTUS Neuro and CRL) (Approx. 50% scientific / 50% BD focus). Key Responsibilities: Scientific & Technical Leadership: Map and analyze potential of FUS modalities together with adjacent biotech innovations. Evaluate convergent CNS technologies: biologics, gene and cell therapies, biomarkers, diagnostics. Lead scientific due diligence in the context of licensing and/or partnerships Translate discoveries into preclinical and support early clinical development roadmaps. (Pre-Clinical/Phase 1-2) Engage KOLs, academic partners, and advisory boards to shape technology strategy as needed Advise internal R&D, Clinical, and Regulatory teams on convergence and combination approaches. Business Development: Lead point of contact on strategic partnerships, co-development deals, licensing opportunities. Lead IP and freedom-to-operate assessment; support negotiation of term sheets and agreements. Manage deal pipeline, CRM tracking, and executive reporting. Develop, manage and present BD strategies and recommendations to leadership. Represent the company at key conferences and partnering meetings. Coordinate cross-functional deal diligence and integration. Qualifications Education: PhD in Neuroscience, Biomedical Engineering, Molecular Biology, or related field (required) MBA or equivalent business training/experience (preferred); MD or MD/PhD also considered Experience: 7–10 years in biotech/pharma/medtech, with 3–5 years in translational R&D (neuro-oncology, CNS delivery, or molecular biotech) 2–3 years in BD, licensing, or partnerships involving CNS assets or platform technologies Proven success in closing licensing or co-development deals Technical Expertise: Strong understanding of CNS drug delivery and BBB challenges Knowledge of biologics, gene/cell therapy, and molecular diagnostics Familiarity with FDA/EMA regulatory pathways for combination products IP and deal-structuring acumen (milestones, royalties, equity) Core Competencies: Strategic and analytical thinking | Scientific-commercial fluency | Cross-functional leadership | Negotiation and communication excellence | Entrepreneurial mindset Reports to: Global Head, Medical Innovation Location: Hybrid or remote; travel ~25% Compensation: Competitive with bonus and equity potential